Expert Interview 1: Frequently Asked Questions (FAQs) for Non-Muscle-Invasive Bladder Cancer (NMIBC)

More details

Join the ACE Oncology Network Today!

Discover the latest updates in oncology, and engage with experts in the field.

JOIN ACE ONCOLOGY NOW

Upcoming Events

See All Upcoming Events
Navigating Treatment Decisions in Advanced NSCLC: <br>Update on Molecular Testing and New Targeted Treatment Options

Navigating Treatment Decisions in Advanced NSCLC:
Update on Molecular Testing and New Targeted Treatment Options

The use of advanced testing technology for genomic profiling (e.g....

Online Education

See All Online Education
article-thumbnail

Expert Interview 1: Frequently Asked Questions (FAQs) for Non-Muscle-Invasive Bladder Cancer (NMIBC)

1 videos / 1 slide decks

Coming Soon

article-thumbnail

Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC)

1 videos / 1 slide decks

article-thumbnail

Expert Interview 3: Frequently Asked Questions (FAQs) for First-Line (1L) Treatment Decision-making in Urothelial Cancer

1 videos / 1 slide decks
article-thumbnail

Focus on Targeting MET Alterations in Advanced NSCLC: A Webinar for Asian Physicians

11 videos / 6 slide decks

Latest Blogs

See Latest Blogs
Highlights from the WCLC 2023 – Targeting MET Alterations

Highlights from the WCLC 2023 – Targeting MET Alterations

The 2023 World Conference on Lung Cancer (WCLC 2023) was held...
FDA Approved 6 New Oncology Indications in August 2023

FDA Approved 6 New Oncology Indications in August 2023

The US FDA approved six new indications for cancer management...
FDA Approved 6 New Oncology Indications in May-July 2023

FDA Approved 6 New Oncology Indications in May-July 2023

The US FDA approved six new indications for cancer management...
FDA Approved Six New Oncology Indications in March-April 2023

FDA Approved Six New Oncology Indications in March-April 2023

The US FDA approved six new indications for cancer management...